Genomic analysis of paired B-ALL samples has inferred clonal structure and evolution through disease progression3,26–28; thus, for example, a transition from a major clone at diagnosis carrying a KRAS.G12D mutation is distinguishable from a major clone at relapse carrying a KRAS.A146T mutation3. The gene discussed is KRAS; the disease is acute lymphoblastic leukemia.